Mihaela State, D MD, PhD
About Mihaela State, D MD, PhD
Mihaela State, D MD, PhD, is the Manager of Clinical Operations at BeiGene in Basel, Switzerland, with over seven years of expertise in clinical development phases II-IV.
Title
Mihaela State currently holds the position of Manager, Clinical Operations at BeiGene in the Basel Area, Switzerland. Her role entails overseeing clinical operations within the organization, ensuring effective project management and adherence to regulatory standards.
Career at Novo Nordisk
Mihaela State worked at Novo Nordisk in various capacities. She served as Clinical Project Manager - EBT in the Rome Area, Italy, from 2018 to 2019 for nine months. Prior to that, she was the Local Trial Manager in Bucharest, Romania, from 2015 to 2019, managing local clinical trials and ensuring compliance with international clinical standards.
Professional Background
Mihaela State has an extensive background in clinical research and project management. She has worked with several prominent pharmaceutical companies, including her tenure as Project Manager/Senior CRA at CEBIS International, outsourced to Abbvie, and as Clinical Research Associate at ICON plc, Servier, and PharmaJobs. Her roles have been instrumental in advancing clinical trials and ensuring their successful execution.
Education and Expertise
Mihaela State holds a PhD in Health Management from Universitatea de Medicina si Farmacie Carol Davila, which she obtained between 2011 and 2015. She also specialized in Dental Medicine, having studied at Titu Maiorescu University from 2004 to 2010. Her academic focus on health management and clinical development has equipped her with the expertise to manage complex clinical operations.
Health Management Research
Mihaela State's research work and PhD thesis were centered on Health Management. Her academic and professional experiences have reinforced her ability to address critical issues in healthcare logistics and administration, enhancing her effectiveness in clinical project management and operational strategy.